CompareMarketResearchRequest a sample
Home / Healthcare / Pharmaceutical Cold Chain

Healthcare · Market report

Pharmaceutical Cold Chain Market Size, Share and Forecast 2026-2036

The global pharmaceutical cold chain market is worth USD 21.6 bn in 2026 and is forecast to reach USD 46.6 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Transportation is the largest by service segment.

USD 21.6 bnMarket size 2026
USD 46.6 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global pharmaceutical cold chain market is worth USD 21.6 bn in 2026 and is forecast to reach USD 46.6 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Transportation is the largest by service segment.

ScopeTemperature-controlled transport, storage, packaging and monitoring of vaccines, biologics and other medicines, covering refrigerated, frozen and ultra-low temperature handling.
IndustryHealthcare
Value 2025USD 20.0 bn
Value 2026USD 21.6 bn
Value 2036USD 46.6 bn
CAGR 2026-20368.0%
Volume 2026421 million shipments
Volume 2036711 million shipments
Average price 2026USD 51.2 per shipment
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Pharmaceutical Cold Chain market size and forecast, 2026-2036

Exhibit 1The global pharmaceutical cold chain market is forecast to grow from USD 21.6 bn in 2026 to USD 46.6 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Pharmaceutical Cold Chain market value, 2025 to 2036Market value by year. 2025: USD 20.0 bn; 2026: USD 21.6 bn; 2027: USD 23.3 bn; 2028: USD 25.2 bn; 2029: USD 27.2 bn; 2030: USD 29.4 bn; 2031: USD 31.7 bn; 2032: USD 34.3 bn; 2033: USD 37.0 bn; 2034: USD 40.0 bn; 2035: USD 43.2 bn; 2036: USD 46.6 bn. Compound annual growth rate 2026 to 2036: 8.0%.202521.6 bn202631.7 bn203146.6 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 21.6 bn
2027USD 23.3 bn
2028USD 25.2 bn
2029USD 27.2 bn
2030USD 29.4 bn
2031USD 31.7 bn
2032USD 34.3 bn
2033USD 37.0 bn
2034USD 40.0 bn
2035USD 43.2 bn
2036USD 46.6 bn

Pharmaceutical Cold Chain market segmentation

By service

Exhibit 2Transportation is the largest segment by service, with 44.0% of 2026 revenueEstimated share of 2026 global revenue, by service
Pharmaceutical Cold Chain market share by service, 2026Share of 2026 revenue by service. Transportation: 44.0%; Storage and warehousing: 24.0%; Packaging and temperature-controlled containers: 22.0%; Monitoring and tracking: 10.0%.Transportation44.0%Storage and warehousing24.0%Packaging and temperature-controlled containers22.0%Monitoring and tracking10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Transportation44.0%40.9%USD 9.5 bn7.2%
Storage and warehousing24.0%22.3%USD 5.2 bn7.2%
Packaging and temperature-controlled containers22.0%23.5%USD 4.8 bn8.7%
Monitoring and tracking10.0%13.4%USD 2.2 bn11.2%

By temperature

Exhibit 3Refrigerated 2 to 8 degrees C adds the most revenue by temperature, growing from USD 14.7 bn in 2026 to USD 27.8 bn by 2036Estimated revenue in USD by temperature, 2026 and 2036 forecast
Pharmaceutical Cold Chain market by temperature, 2026 and 2036Revenue by temperature in 2026 and 2036. Refrigerated 2 to 8 degrees C: USD 14.7 bn in 2026, USD 27.8 bn in 2036, change +90%; Frozen: USD 4.3 bn in 2026, USD 10.3 bn in 2036, change +139%; Ultra-low and cryogenic: USD 2.6 bn in 2026, USD 8.5 bn in 2036, change +227%.20262036 forecastChangeRefrigerated 2 to 8 degrees C+90%14.7 bn27.8 bnFrozen+139%4.3 bn10.3 bnUltra-low and cryogenic+227%2.6 bn8.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Refrigerated 2 to 8 degrees C68.0%59.7%USD 14.7 bn6.6%
Frozen20.0%22.1%USD 4.3 bn9.1%
Ultra-low and cryogenic12.0%18.2%USD 2.6 bn12.6%

By product

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biologics and vaccines52.0%54.2%USD 11.2 bn8.4%
Cell and gene therapy6.0%14.4%USD 1.3 bn17.9%
Clinical trial material12.0%10.9%USD 2.6 bn7.0%
Other drugs30.0%20.5%USD 6.5 bn4.0%

By mode of transport

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Road42.0%38.0%USD 9.1 bn6.9%
Air34.0%34.0%USD 7.3 bn8.0%
Sea14.0%14.0%USD 3.0 bn8.0%
Rail and multimodal10.0%14.0%USD 2.2 bn11.7%

By packaging

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Insulated shippers36.0%32.0%USD 7.8 bn6.7%
Active temperature-controlled containers28.0%34.0%USD 6.0 bn10.1%
Refrigerated storage systems36.0%34.0%USD 7.8 bn7.4%

Top 25 countries for pharmaceutical cold chain by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 79.5% of 2026 revenue and the 25 countries below together hold 94.2%.

Exhibit 4United States is the largest country market at USD 7.3 bn in 2026, and the three largest countries hold 50.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Pharmaceutical Cold Chain market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 7.3 bn, 34.0%; Germany: USD 1.7 bn, 8.0%; China: USD 1.7 bn, 8.0%; United Kingdom: USD 1.3 bn, 6.0%; Japan: USD 1.1 bn, 5.0%; France: USD 1.1 bn, 5.0%; India: USD 864 mn, 4.0%; Netherlands: USD 756 mn, 3.5%; Belgium: USD 648 mn, 3.0%; Switzerland: USD 648 mn, 3.0%.United States7.3 bn 34.0%Germany1.7 bn 8.0%China1.7 bn 8.0%United Kingdom1.3 bn 6.0%Japan1.1 bn 5.0%France1.1 bn 5.0%India864 mn 4.0%Netherlands756 mn 3.5%Belgium648 mn 3.0%Switzerland648 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 7.3 bn34.0%USD 15.3 bn7.7%
2GermanyUSD 1.7 bn8.0%USD 3.5 bn7.2%
3ChinaUSD 1.7 bn8.0%USD 4.8 bn10.7%
4United KingdomUSD 1.3 bn6.0%USD 2.6 bn7.1%
5JapanUSD 1.1 bn5.0%USD 2.0 bn6.1%
6FranceUSD 1.1 bn5.0%USD 2.1 bn6.6%
7IndiaUSD 864 mn4.0%USD 2.7 bn12.1%
8NetherlandsUSD 756 mn3.5%USD 1.5 bn7.0%
9BelgiumUSD 648 mn3.0%USD 1.3 bn7.3%
10SwitzerlandUSD 648 mn3.0%USD 1.3 bn7.3%
11SpainUSD 529 mn2.5%USD 1.2 bn8.1%
12ItalyUSD 421 mn1.9%USD 923 mn8.2%
13CanadaUSD 350 mn1.6%USD 765 mn8.1%
14AustraliaUSD 300 mn1.4%USD 658 mn8.2%
15South KoreaUSD 279 mn1.3%USD 611 mn8.2%
16MexicoUSD 231 mn1.1%USD 504 mn8.1%
17BrazilUSD 190 mn0.9%USD 420 mn8.2%
18TurkeyUSD 177 mn0.8%USD 387 mn8.1%
19PolandUSD 158 mn0.7%USD 345 mn8.2%
20SwedenUSD 125 mn0.6%USD 275 mn8.2%
21SingaporeUSD 112 mn0.5%USD 247 mn8.2%
22DenmarkUSD 102 mn0.5%USD 219 mn8.0%
23IrelandUSD 86 mn0.4%USD 191 mn8.3%
24Saudi ArabiaUSD 69 mn0.3%USD 149 mn8.0%
25TaiwanUSD 56 mn0.3%USD 126 mn8.4%
Rest of worldUSD 1.2 bn5.8%USD 2.7 bn8.2%
Exhibit 5United States and China account for 44% of the USD 25.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Pharmaceutical Cold Chain market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 21.6 bn. United States: +USD 8.0 bn; China: +USD 3.0 bn; India: +USD 1.8 bn; Germany: +USD 1.7 bn; United Kingdom: +USD 1.3 bn; 20 other countries: +USD 7.7 bn; Rest of world: +USD 1.5 bn. Market value 2036: USD 46.6 bn.Market value 202621.6 bnUnited States+8.0 bnChina+3.0 bnIndia+1.8 bnGermany+1.7 bnUnited Kingdom+1.3 bn20 other countries+7.7 bnRest of world+1.5 bnMarket value 203646.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • DHL
  • UPS Healthcare
  • FedEx
  • Kuehne+Nagel
  • World Courier
  • DSV
  • DB Schenker

Group 2: Regional and specialist players

  • Cryoport
  • Sonoco ThermoSafe
  • Va-Q-tec
  • Cold Chain Technologies
  • Marken
  • Biocair
  • Controlant
  • Sensitech
  • Tempack Packaging

Group 3: Emerging and niche players

  • Pelican BioThermal
  • Envirotainer
  • Tive
  • SkyCell
  • Savsu Technologies

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the pharmaceutical cold chain market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by service, by temperature, by product, by mode of transport, by packaging. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the pharmaceutical cold chain market?

The global pharmaceutical cold chain market is estimated at USD 20.0 bn in 2025 and USD 21.6 bn in 2026.

How fast will the pharmaceutical cold chain market grow?

It is forecast to reach USD 46.6 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 25.0 bn.

Which country is the largest market for pharmaceutical cold chain?

United States is the largest market by revenue at USD 7.3 bn in 2026, 34.0% of the global total. The three largest countries together hold 50.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 12.1% a year from 2026 to 2036.

Which pharmaceutical cold chain segment is largest?

In the by service split, Transportation is the largest segment with 44.0% of 2026 revenue.

Who are the leading pharmaceutical cold chain companies?

Global leaders include DHL, UPS Healthcare, FedEx, Kuehne+Nagel.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Pharmaceutical Closure Pharmaceutical Distribution →

All Healthcare markets →

Request a sample